Australia markets close in 2 hours 10 minutes

Yield10 Bioscience, Inc. (YTEN)

NasdaqCM - NasdaqCM Delayed price. Currency in USD
Add to watchlist
2.0600-0.0500 (-2.37%)
At close: 03:24PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 1.36M
Enterprise value 2.79M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)2.40
Price/book (mrq)N/A
Enterprise value/revenue 7.74
Enterprise value/EBITDA N/A

Trading information

Stock price history

Beta (5Y monthly) 1.70
52-week change 3-96.93%
S&P500 52-week change 326.94%
52-week high 372.9600
52-week low 32.0000
50-day moving average 36.0114
200-day moving average 36.7492

Share statistics

Avg vol (3-month) 3179.97k
Avg vol (10-day) 361.27k
Shares outstanding 5642.55k
Implied shares outstanding 6642.55k
Float 8560.22k
% held by insiders 112.59%
% held by institutions 111.79%
Shares short (30 Apr 2024) 42.53k
Short ratio (30 Apr 2024) 40.03
Short % of float (30 Apr 2024) 40.41%
Short % of shares outstanding (30 Apr 2024) 40.39%
Shares short (prior month 28 Mar 2024) 439.2k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 316 Jan 2020
Ex-dividend date 4N/A
Last split factor 21:24
Last split date 303 May 2024

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 0.00%
Operating margin (ttm)-24,028.33%

Management effectiveness

Return on assets (ttm)-150.28%
Return on equity (ttm)-1,508.09%

Income statement

Revenue (ttm)60k
Revenue per share (ttm)0.18
Quarterly revenue growth (yoy)-100.00%
Gross profit (ttm)N/A
EBITDA -14.13M
Net income avi to common (ttm)-14.46M
Diluted EPS (ttm)-29.5700
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)1.07M
Total cash per share (mrq)1.66
Total debt (mrq)3.18M
Total debt/equity (mrq)N/A
Current ratio (mrq)0.29
Book value per share (mrq)-4.95

Cash flow statement

Operating cash flow (ttm)-10.07M
Levered free cash flow (ttm)-4.57M